DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,353,015 | -25.4% | 114,058 | +6.8% | 0.01% | -16.7% |
Q2 2023 | $3,152,080 | +66.2% | 106,814 | +29.8% | 0.01% | +50.0% |
Q1 2023 | $1,896,076 | -31.4% | 82,295 | -17.2% | 0.00% | -33.3% |
Q4 2022 | $2,763,562 | -15.7% | 99,373 | -7.0% | 0.01% | -14.3% |
Q3 2022 | $3,277,000 | +26.3% | 106,861 | +21.1% | 0.01% | +40.0% |
Q2 2022 | $2,595,000 | +56.7% | 88,230 | +71.3% | 0.01% | +66.7% |
Q1 2022 | $1,656,000 | -43.9% | 51,520 | -22.1% | 0.00% | -40.0% |
Q4 2021 | $2,952,000 | -10.1% | 66,121 | +1.2% | 0.01% | -16.7% |
Q3 2021 | $3,284,000 | -34.1% | 65,351 | +2.5% | 0.01% | -25.0% |
Q2 2021 | $4,986,000 | +82.9% | 63,757 | +32.9% | 0.01% | +60.0% |
Q1 2021 | $2,726,000 | -59.4% | 47,966 | -40.1% | 0.01% | -61.5% |
Q4 2020 | $6,710,000 | +243.0% | 80,095 | +46.7% | 0.01% | +225.0% |
Q3 2020 | $1,956,000 | +48.3% | 54,599 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $1,319,000 | +5.1% | 54,599 | -23.9% | 0.00% | 0.0% |
Q1 2020 | $1,255,000 | -38.4% | 71,729 | -38.7% | 0.00% | -25.0% |
Q4 2019 | $2,036,000 | +92.1% | 116,919 | +69.1% | 0.00% | +100.0% |
Q3 2019 | $1,060,000 | +44.0% | 69,123 | +94.5% | 0.00% | +100.0% |
Q2 2019 | $736,000 | +22.5% | 35,540 | +37.3% | 0.00% | 0.0% |
Q1 2019 | $601,000 | +73.2% | 25,890 | +54.1% | 0.00% | 0.0% |
Q4 2018 | $347,000 | – | 16,796 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 19,462,500 | $298,165,000 | 48.02% |
Bratton Capital Management, L.P. | 953,035 | $14,600,000 | 28.53% |
Flagship Pioneering Inc. | 8,005,747 | $122,648,000 | 6.71% |
Casdin Capital, LLC | 650,000 | $9,958,000,000 | 1.03% |
Temasek Holdings (Private) Ltd | 4,410,457 | $67,568,000 | 0.50% |
MARK ASSET MANAGEMENT LP | 68,864 | $1,055,000 | 0.26% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 22,507 | $345,000 | 0.26% |
Artal Group S.A. | 400,000 | $6,128,000 | 0.25% |
PIER 88 INVESTMENT PARTNERS LLC | 40,610 | $622,000 | 0.24% |
HAMILTON LANE ADVISORS LLC | 30,948 | $474,000 | 0.20% |